Evidence map›Paper›PMID 21675818›Full record

ArticleInternational journal of radiation biology2011

Mitigation of radiation-induced lung injury by genistein and EUK-207.

Javed Mahmood, Salomeh Jelveh, Victoria Calveley, Asif Zaidi, Susan R Doctrow, Richard P Hill

Abstract read
In one paragraph

Article in International journal of radiation biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Balanced Duality: HInternational journal of molecular sciences · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Mitigation of Radiation-induced Pneumonitis and Lung Fibrosis using Alpha-lipoic Acid and Resveratrol.Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Pharmacology of natural radioprotectors.Archives of pharmacal research · 2018
    Review
  17. Article
  18. Mechanisms of Normal Tissue Injury From Irradiation.Seminars in radiation oncology · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Javed MahmoodOntario Cancer Institute/Princess Margaret Hospital, University Health Network, and the Campbell Family Institute for Cancer Research, Toronto, Ontario, Canada.
Salomeh Jelveh
Victoria Calveley
Asif Zaidi
Susan R Doctrow
Richard P Hill
Ontario Institute for Cancer Research · CAPrincess Margaret Cancer Centre · CABoston University · US

Funding

Training and educationU19AI067734 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI OTTERSON, MARY F. · 2005 to 2009
$18.2M
CIHR 144089NIAID NIH HHS U19 AI-067734NIAID NIH HHS U19 AI067734
6 · The paper itself

Abstract

purposeWe examined the effects of genistein and/or Eukarion (EUK)-207 on radiation-induced lung damage and investigated whether treatment for 0-14 weeks (wks) post-irradiation (PI) would mitigate late lung injury. MATERIALS AND

methodsThe lungs of female Sprague-Dawley (SD) rats were irradiated with 10 Gy. EUK-207 was delivered by infusion and genistein was delivered as a dietary supplement starting immediately after irradiation (post irradiation [PI]) and continuing until 14 wks PI. Rats were sacrificed at 0, 4, 8, 14 and 28 wks PI. Breathing rate was monitored and lung fibrosis assessed by lung hydroxyproline content at 28 wks. DNA damage was assessed by micronucleus (MN) assay and 8-hydroxy-2-deoxyguanosine (8-OHdG) levels. The expression of the cytokines Interleukin (IL)-1α, IL-1β, IL-6, Tumor necrosis factor (TNF)-α and Transforming growth factor (TGF)-β1, and macrophage activation were analyzed by immunohistochemistry.

resultsIncreases in breathing rate observed in the irradiated rats were significantly reduced by both drug treatments during the pneumonitis phase and the later fibrosis phase. The drug treatments decreased micronuclei (MN) formation from 4-14 wks but by 28 wks the MN levels had increased again. The 8-OHdG levels were lower in the drug treated animals at all time points. Hydroxyproline content and levels of activated macrophages were decreased at 28 wks in all drug treated rats. The treatments had limited effects on the expression of the cytokines.

conclusionGenistein and EUK-207 can provide partial mitigation of radiation-induced lung damage out to at least 28 wks PI even after cessation of treatment at 14 wks PI.

Indexed as

AnimalsFemaleGenisteinOrganometallic CompoundsRadiation PneumonitisRadiation-Protective AgentsRatsRats, Sprague-DawleyRespiratory MechanicsTreatment OutcomeEUK 207GenisteinOrganometallic CompoundsRadiation-Protective Agents

Identifiers

PMID21675818
PMCPMC3155801
OpenAlexW1988268961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.